7591 related articles for article (PubMed ID: 18501566)
1. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
[TBL] [Abstract][Full Text] [Related]
2. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
3. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
Akiskal HS; Benazzi F; Perugi G; Rihmer Z
J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
[TBL] [Abstract][Full Text] [Related]
4. Classifying mood disorders by age-at-onset instead of polarity.
Benazzi F
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):86-93. PubMed ID: 18992784
[TBL] [Abstract][Full Text] [Related]
5. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
6. Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.
Amsterdam JD; Wang CH; Shwarz M; Shults J
J Affect Disord; 2009 Jan; 112(1-3):219-30. PubMed ID: 18486235
[TBL] [Abstract][Full Text] [Related]
7. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
[TBL] [Abstract][Full Text] [Related]
8. Bipolar II disorder : epidemiology, diagnosis and management.
Benazzi F
CNS Drugs; 2007; 21(9):727-40. PubMed ID: 17696573
[TBL] [Abstract][Full Text] [Related]
9. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.
Cerbo AD
Turk Psikiyatri Derg; 2021; 32(4):293-295. PubMed ID: 34964106
[TBL] [Abstract][Full Text] [Related]
10. Validating the bipolar spectrum in the French National EPIDEP Study: overview of the phenomenology and relative prevalence of its clinical prototypes.
Akiskal HS; Akiskal KK; Lancrenon S; Hantouche EG; Fraud JP; Gury C; Allilaire JF
J Affect Disord; 2006 Dec; 96(3):197-205. PubMed ID: 16824616
[TBL] [Abstract][Full Text] [Related]
11. Irritable-hostile depression: further validation as a bipolar depressive mixed state.
Benazzi F; Akiskal H
J Affect Disord; 2005 Feb; 84(2-3):197-207. PubMed ID: 15708417
[TBL] [Abstract][Full Text] [Related]
12. [Alpha-interferon and mental disorders].
Debien C; De Chouly De Lenclave MB; Foutrein P; Bailly D
Encephale; 2001; 27(4):308-17. PubMed ID: 11686052
[TBL] [Abstract][Full Text] [Related]
13. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).
Vieta E; Angst J; Reed C; Bertsch J; Haro JM;
J Affect Disord; 2009 Nov; 118(1-3):118-23. PubMed ID: 19269690
[TBL] [Abstract][Full Text] [Related]
14. [Methodological approach to inter "guideline" variability in the management of bipolar disorders].
Samalin L; Llorca PM
Encephale; 2012 Apr; 38(2):126-32. PubMed ID: 22516270
[TBL] [Abstract][Full Text] [Related]
15. [Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context].
Auxéméry Y
Encephale; 2012 Oct; 38(5):373-80. PubMed ID: 23062450
[TBL] [Abstract][Full Text] [Related]
16. [The difference between depression and melancholia: two distinct conditions that were combined into a single category in DSM-III].
Ohmae S
Seishin Shinkeigaku Zasshi; 2012; 114(8):886-905. PubMed ID: 23012851
[TBL] [Abstract][Full Text] [Related]
17. Why do clinicians maintain antidepressants in some patients with acute mania? Hints from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM), a large naturalistic study.
Rosa AR; Cruz N; Franco C; Haro JM; Bertsch J; Reed C; Aarre TF; Sanchez-Moreno J; Vieta E
J Clin Psychiatry; 2010 Aug; 71(8):1000-6. PubMed ID: 20361912
[TBL] [Abstract][Full Text] [Related]
18. Four-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotype.
Geller B; Tillman R; Craney JL; Bolhofner K
Arch Gen Psychiatry; 2004 May; 61(5):459-67. PubMed ID: 15123490
[TBL] [Abstract][Full Text] [Related]
19. [Frequency and clinical aspects of bipolar II disorder in a French multicenter study: EPIDEP].
Allilaire JF; Hantouche EG; Sechter D; Bourgeois ML; Azorin JM; Lancrenon S; Châtenet-Duchêne L; Akiskal HS
Encephale; 2001; 27(2):149-58. PubMed ID: 11407267
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE study.
Angst J; Azorin JM; Bowden CL; Perugi G; Vieta E; Gamma A; Young AH;
Arch Gen Psychiatry; 2011 Aug; 68(8):791-8. PubMed ID: 21810644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
